PETS — PetMed Express Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousMicro CapContrarian

Annual income statement for PetMed Express, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2021 March 31st	R2022 March 31st	2023 March 31st	C2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K/A	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	309	272	257	274	227
Cost of Revenue
Gross Profit	89.9	76.9	70.7	84.8	69.1
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	272	248	251	282	229
Operating Profit	37.6	24.3	6.05	-8.16	-1.53
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	39.2	24.2	7.45	-6.27	-0.587
Provision for Income Taxes
Net Income After Taxes	30.6	18.7	5.14	-7.46	-6.27
Net Income Before Extraordinary Items
Net Income	30.6	18.7	5.14	-7.46	-6.27
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	30.6	18.7	5.14	-7.46	-6.27
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.52	0.919	0.33	-0.296	-0.236
Dividends per Share